Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit

ABSTRACT Human antibody-based immunity to influenza A virus is limited by antigenic drift resulting from amino acid substitutions in the hemagglutinin (HA) head domain. Glycan addition can cause large antigenic changes but is limited by fitness costs to viral replication. Here, we report that glycan...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Meghan O. Altman, Matthew Angel, Ivan Košík, Nídia S. Trovão, Seth J. Zost, James S. Gibbs, Lorenzo Casalino, Rommie E. Amaro, Scott E. Hensley, Martha I. Nelson, Jonathan W. Yewdell
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2019
Materias:
Acceso en línea:https://doaj.org/article/b7c5ac3ce6cf49fcb5e61be2761289cd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b7c5ac3ce6cf49fcb5e61be2761289cd
record_format dspace
spelling oai:doaj.org-article:b7c5ac3ce6cf49fcb5e61be2761289cd2021-11-15T15:55:26ZHuman Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit10.1128/mBio.00204-192150-7511https://doaj.org/article/b7c5ac3ce6cf49fcb5e61be2761289cd2019-04-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00204-19https://doaj.org/toc/2150-7511ABSTRACT Human antibody-based immunity to influenza A virus is limited by antigenic drift resulting from amino acid substitutions in the hemagglutinin (HA) head domain. Glycan addition can cause large antigenic changes but is limited by fitness costs to viral replication. Here, we report that glycans are added to H1 and H3 HAs at discrete 5-to-7-year intervals, until they reach a functional glycan limit, after which glycans are swapped at approximately 2-fold-longer intervals. Consistent with this pattern, 2009 pandemic H1N1 added a glycan at residue N162 over the 2015–2016 season, an addition that required two epistatic HA head mutations for complete glycosylation. These strains rapidly replaced H1N1 strains globally, by 2017 dominating H3N2 and influenza B virus strains for the season. The pattern of glycan modulation that we outline should aid efforts for tracing the epidemic potential of evolving human IAV strains. IMPORTANCE Frequent mutation of its major antibody target, the glycoprotein hemagglutinin, ensures that the influenza virus is perennially both a rapidly emerging virus and a major threat to public health. One type of mutation escapes immunity by adding a glycan onto an area of hemagglutinin that many antibodies recognize. This study revealed that these glycan changes follow a simple temporal pattern. Every 5 to 7 years, hemagglutinin adds a new glycan, up to a limit. After this limit is reached, no net additions of glycans occur. Instead, glycans are swapped or lost at longer intervals. Eventually, a pandemic replaces the terminally glycosylated hemagglutinin with a minimally glycosylated one from the animal reservoir, restarting the cycle. This pattern suggests the following: (i) some hemagglutinins are evolved for this decades-long process, which is both defined by and limited by successive glycan addition; and (ii) hemagglutinin's antibody dominance and its capacity for mutations are highly adapted features that allow influenza to outpace our antibody-based immunity.Meghan O. AltmanMatthew AngelIvan KošíkNídia S. TrovãoSeth J. ZostJames S. GibbsLorenzo CasalinoRommie E. AmaroScott E. HensleyMartha I. NelsonJonathan W. YewdellAmerican Society for Microbiologyarticleinfluenzaviral evolutionhemagglutininimmune evasionglycosylationMicrobiologyQR1-502ENmBio, Vol 10, Iss 2 (2019)
institution DOAJ
collection DOAJ
language EN
topic influenza
viral evolution
hemagglutinin
immune evasion
glycosylation
Microbiology
QR1-502
spellingShingle influenza
viral evolution
hemagglutinin
immune evasion
glycosylation
Microbiology
QR1-502
Meghan O. Altman
Matthew Angel
Ivan Košík
Nídia S. Trovão
Seth J. Zost
James S. Gibbs
Lorenzo Casalino
Rommie E. Amaro
Scott E. Hensley
Martha I. Nelson
Jonathan W. Yewdell
Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit
description ABSTRACT Human antibody-based immunity to influenza A virus is limited by antigenic drift resulting from amino acid substitutions in the hemagglutinin (HA) head domain. Glycan addition can cause large antigenic changes but is limited by fitness costs to viral replication. Here, we report that glycans are added to H1 and H3 HAs at discrete 5-to-7-year intervals, until they reach a functional glycan limit, after which glycans are swapped at approximately 2-fold-longer intervals. Consistent with this pattern, 2009 pandemic H1N1 added a glycan at residue N162 over the 2015–2016 season, an addition that required two epistatic HA head mutations for complete glycosylation. These strains rapidly replaced H1N1 strains globally, by 2017 dominating H3N2 and influenza B virus strains for the season. The pattern of glycan modulation that we outline should aid efforts for tracing the epidemic potential of evolving human IAV strains. IMPORTANCE Frequent mutation of its major antibody target, the glycoprotein hemagglutinin, ensures that the influenza virus is perennially both a rapidly emerging virus and a major threat to public health. One type of mutation escapes immunity by adding a glycan onto an area of hemagglutinin that many antibodies recognize. This study revealed that these glycan changes follow a simple temporal pattern. Every 5 to 7 years, hemagglutinin adds a new glycan, up to a limit. After this limit is reached, no net additions of glycans occur. Instead, glycans are swapped or lost at longer intervals. Eventually, a pandemic replaces the terminally glycosylated hemagglutinin with a minimally glycosylated one from the animal reservoir, restarting the cycle. This pattern suggests the following: (i) some hemagglutinins are evolved for this decades-long process, which is both defined by and limited by successive glycan addition; and (ii) hemagglutinin's antibody dominance and its capacity for mutations are highly adapted features that allow influenza to outpace our antibody-based immunity.
format article
author Meghan O. Altman
Matthew Angel
Ivan Košík
Nídia S. Trovão
Seth J. Zost
James S. Gibbs
Lorenzo Casalino
Rommie E. Amaro
Scott E. Hensley
Martha I. Nelson
Jonathan W. Yewdell
author_facet Meghan O. Altman
Matthew Angel
Ivan Košík
Nídia S. Trovão
Seth J. Zost
James S. Gibbs
Lorenzo Casalino
Rommie E. Amaro
Scott E. Hensley
Martha I. Nelson
Jonathan W. Yewdell
author_sort Meghan O. Altman
title Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit
title_short Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit
title_full Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit
title_fullStr Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit
title_full_unstemmed Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit
title_sort human influenza a virus hemagglutinin glycan evolution follows a temporal pattern to a glycan limit
publisher American Society for Microbiology
publishDate 2019
url https://doaj.org/article/b7c5ac3ce6cf49fcb5e61be2761289cd
work_keys_str_mv AT meghanoaltman humaninfluenzaavirushemagglutininglycanevolutionfollowsatemporalpatterntoaglycanlimit
AT matthewangel humaninfluenzaavirushemagglutininglycanevolutionfollowsatemporalpatterntoaglycanlimit
AT ivankosik humaninfluenzaavirushemagglutininglycanevolutionfollowsatemporalpatterntoaglycanlimit
AT nidiastrovao humaninfluenzaavirushemagglutininglycanevolutionfollowsatemporalpatterntoaglycanlimit
AT sethjzost humaninfluenzaavirushemagglutininglycanevolutionfollowsatemporalpatterntoaglycanlimit
AT jamessgibbs humaninfluenzaavirushemagglutininglycanevolutionfollowsatemporalpatterntoaglycanlimit
AT lorenzocasalino humaninfluenzaavirushemagglutininglycanevolutionfollowsatemporalpatterntoaglycanlimit
AT rommieeamaro humaninfluenzaavirushemagglutininglycanevolutionfollowsatemporalpatterntoaglycanlimit
AT scottehensley humaninfluenzaavirushemagglutininglycanevolutionfollowsatemporalpatterntoaglycanlimit
AT marthainelson humaninfluenzaavirushemagglutininglycanevolutionfollowsatemporalpatterntoaglycanlimit
AT jonathanwyewdell humaninfluenzaavirushemagglutininglycanevolutionfollowsatemporalpatterntoaglycanlimit
_version_ 1718427171992633344